Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib in HIV-Related Kaposi's Sarcoma
NCT00090987Phase 2Completed
- Sponsor
- AIDS Malignancy Consortium
- Start
- Jun 2005
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of imatinib in Kaposi sarcoma (KS), sponsored by AIDS Malignancy Consortium. Primary endpoint: Proportion of Patients Who Achieve a Clinical Response. Started Jun 2005; status: completed.
02
Drugs
03
Conditions
Kaposi sarcoma (KS)
Beyond the preview
Go deeper on NCT00090987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00090987.